Contact
Please use this form to send email to PR contact of this press release:
Denali Therapeutics Announces Broad Pipeline Progress Including Positive Results From Its LRRK2 Program for Parkinson’s Disease
TO:
Please use this form to send email to PR contact of this press release:
Denali Therapeutics Announces Broad Pipeline Progress Including Positive Results From Its LRRK2 Program for Parkinson’s Disease
TO: